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Lysine acetylation (AcK), a posttranslational modifi-
cation wherein a two-carbon acetyl group binds
covalently to a lysine residue, occurs prominently
on mitochondrial proteins and has been linked to
metabolic dysfunction. An emergent theory suggests
mitochondrial AcK occurs via mass action rather
than targeted catalysis. To test this hypothesis, we
performed mass spectrometry-based acetylproteo-
mic analyses of quadriceps muscles from mice with
skeletal muscle-specific deficiency of carnitine ace-
tyltransferase (CrAT), an enzyme that buffers the
mitochondrial acetyl-CoA pool by converting short-
chain acyl-CoAs to their membrane permeant acyl-
carnitine counterparts. CrAT deficiency increased
tissue acetyl-CoA levels and susceptibility to diet-
induced AcK of broad-ranging mitochondrial pro-
teins, coincident with diminished whole body
glucose control. Sub-compartment acetylproteome
analyses of muscles from obese mice and humans
showed remarkable overrepresentation of mitochon-
drial matrix proteins. These findings reveal roles for
CrAT and L-carnitine in modulating the muscle ace-
tylproteome and provide strong experimental evi-
dence favoring the nonenzymatic carbon pressure
model of mitochondrial AcK.INTRODUCTION
The recent epidemic surge in the rates of obesity and closely
related metabolic diseases has sparked intense research aimed
at understanding the cellular and molecular consequences of
persistent overnutrition (Ogden et al., 2014). Among manyCadverse outcomes of chronic positive energy imbalance is a
steady decay in mitochondrial performance (Lowell and Shul-
man, 2005). These organelles are increasingly recognized as a
key regulatory hub for processes such as nutrient sensing, retro-
grade signaling, autophagy, and cell survival, in addition to their
well-established roles in ATP production and cellular bioener-
getics (Pagliarini and Rutter, 2013). Accordingly, disease-associ-
ated perturbations in mitochondrial quality and function have
broad-ranging clinical and therapeutic implications.
While many disease states are characterized by perturbed
expression of multiple genes involved in respiratory function
(Mootha et al., 2003), dysregulation at the genomic level does
not fully explain the changes in mitochondrial bioenergetics
frequently associated with obesity and diabetes (Holloszy,
2009). Also contributing to obesity-induced perturbations in
mitochondrial performance, are several posttranslational modifi-
cations (PTMs) that modulate stability, turnover, and/or function
of mitochondrial proteins. Recent applications of mass spec-
trometry has drawn attention to lysine acetylation as a prominent
mitochondrial PTM that is increasingly recognized as amarker of
cellular energy stress (Dittenhafer-Reed et al., 2015; Hebert
et al., 2013; Kendrick et al., 2011; Rardin et al., 2013; Still
et al., 2013). Protein acetylation is a reversible modification in
which a two-carbon acetyl group is covalently bound to the
ε-amino group of a lysine residue (Anderson and Hirschey,
2012). A growing number of reports provide evidence that acet-
ylation of certain lysines can affect mitochondrial protein interac-
tions, function, and/or enzymatic activities (Bharathi et al., 2013;
Hirschey, 2011; Hirschey et al., 2010, 2011; Jing et al., 2011; Still
et al., 2013). The strongest evidence that these PTMs can impart
adverse physiologic consequences comes frommice lacking sir-
tuin 3 (SIRT3), a NAD+-dependent deacetylase that removes
acetyl groups from specific lysine residues (Hebert et al., 2013;
Newman et al., 2012; Rardin et al., 2013). SIRT3-deficient mice
display varying degrees of increased mitochondrial protein acet-
ylation within key metabolic tissues and develop symptoms
reminiscent of the metabolic syndrome when challenged byell Reports 14, 243–254, January 12, 2016 ª2016 The Authors 243
high fat feeding (Dittenhafer-Reed et al., 2015; Hirschey et al.,
2011; Lantier et al., 2015).
Whereas this field has been steadily gaining knowledge about
the enzymes and physiological circumstances that regulate
mitochondrial protein deacylation, the biological factors that in-
fluence the addition of acetyl groups to lysine side chains remain
poorly understood. One idea gaining increasing traction sug-
gests that unlike acylation reactions in other subcellular com-
partments, acetylation of mitochondrial proteins occurs largely
through non-enzymatic mechanisms as a consequence of
mass action, rather than targeted catalysis (Ghanta et al.,
2013; Wagner and Payne, 2013). This model predicts that phys-
iological and nutritional conditions that raise mitochondrial con-
centrations of acetyl-CoA ‘‘push’’ these protein modifications by
expanding the local pool of acetyl donors. Relevant to this hy-
pothesis is evidence that overfeeding results in incomplete
oxidation of carbon fuels, reflected by increased accumulation
of mitochondrial-derived acylcarnitine species that originate
from their corresponding acyl-CoA precursors (Koves et al.,
2008). Taken together, these findings imply that chronic energy
surplus results in a mismatch between substrate supply and de-
mand, which in turn increasesmitochondrial carbon load (Muoio,
2014). Also related to this general model are recent studies
showing that mitochondrial acetyl-CoA balance can be nutrition-
ally regulated via the carnitine-dependent enzyme, carnitine ace-
tyltransferase (CrAT). This enzyme is most abundant in skeletal
muscle and heart and localizes to the mitochondrial matrix
(Muoio et al., 2012; Noland et al., 2009; Seiler et al., 2015). The
freely reversible CrAT reaction interconverts short-chain acyl-
CoAs and their corresponding carnitine conjugates. Importantly,
unlike their acyl-CoA precursors, acylcarnitine metabolites can
traverse the inner mitochondrial membrane and thereby permit
mitochondrial efflux of excess acyl moieties. These findings raise
the intriguing possibility that this acetyl group buffering system
plays a key role in mitigating nutrient-induced acetylation of
mitochondrial proteins.
The goal of the current study was to test the hypothesis that
macronutrient load and carnitine-mediated acetyl group buff-
ering directly impact mitochondrial protein acetylation in skeletal
muscle. To this end, we employed a label-free quantitative mass
spectrometry-based acetylproteomics approach to examine the
consequences of skeletal muscle-specific CrAT deficiency on
diet-induced acetylation of mitochondrial proteins. Our findings
not only establish important roles for CrAT and L-carnitine in
modulating the muscle acetylproteome, but also provide strong
experimental evidence that advances the ‘‘carbon pressure’’
concept of mitochondrial lysine acetylation.
RESULTS
Carnitine and CrAT Mitigate Acetyl-CoA-Induced
Acetylation of Mitochondrial Proteins In Vitro
Provision of L-carnitine to muscle mitochondria permits CrAT-
mediated conversion of acetyl-CoA to acetylcarnitine (Noland
et al., 2009). The potential role of L-carnitine in offsetting
acetyl-CoA-induced lysine acetylation of skeletal muscle
mitochondrial proteins was initially tested in vitro using a per-
meabilized mitochondrial incubation system combined with244 Cell Reports 14, 243–254, January 12, 2016 ª2016 The Authorsimmunoblot analysis using an anti-acetyllysine antibody.
Consistent with previous reports (Wagner and Payne, 2013),
total acetylation of proteins in isolated mitochondria increased
when the concentration of acetyl-CoA in the incubation buffer
was raised from 0 to 2.5 mM, the latter of which is within the esti-
mated physiologic range (Hansford and Johnson, 1975; Wagner
and Payne, 2013) (Figure 1A). Addition of 5 mM L-carnitine re-
sulted in a near-complete block of detectable acetyl-CoA-
induced acetylation of several mitochondrial proteins, whereas
other bands were unaffected (Figure 1A). To determine whether
this effect of L-carnitine depends on the acetyl-CoA-buffering
activity of CrAT, we repeated similar experiments using
mitochondria prepared from CrATskm/ mice, which lack the
enzyme specifically in skeletal muscle, as well as CrATfl/fl litter-
mate control animals (Seiler et al., 2015). As anticipated, L-carni-
tine failed to defend against protein acetylation when provided to
mitochondrial lysates prepared from CrAT-deficient muscles
(Figures 1B and 1C). Abundance of the mitochondrial electron
transferring flavoprotein (ETF), used as a loading control, was
unaffected by genotypes and carnitine treatment.
Results of the in vitro assays strongly implied a role for the
CrAT/L-carnitine system in regulating mitochondrial protein
acetylation. To assess this possibility in vivo, we evaluated total
lysine acetylation by western blot analysis of isolated muscle
mitochondria harvested from CrATfl/fl and CrATskm/ mice fed
a high fat (HF) diet for 12 weeks. Notably, CrAT deficiency
increased tissue levels of acetyl-CoA (Figure 1D) as well as total
abundance of lysine-acetylated proteins (Figure 1E). Consid-
ering that CrAT resides in the mitochondrial matrix, we presume
the increase in tissue acetyl-CoA content reflects changes in this
compartment specifically.
High Fat Feeding Expands the Detectable Acetyl-
Proteome in Skeletal Muscle
To gain further insights into the impact of nutrient load and CrAT
activity on the muscle acetylome, we began by evaluating the in-
ventories of acetylated peptides detected in quadriceps tissue
from CrATfl/fl control mice fed either a low fat (LF) or HF diet.
Our proteomics strategy (Figure 2A) combined enzymatic diges-
tion of the whole-tissue lysate, antibody-based acetylpeptide
enrichment, and nanoflow reverse-phase liquid chromatog-
raphy-tandem mass spectrometry (LC-MS/MS). The acetylpep-
tides identified at a 1% false discovery rate (FDR) mapped to a
total of 911 non-redundant sites of acetylation, of which 279
were identified in both diets, 542 were identified only in mice
fed the HF diet, and 90 were identified only in the LF group (Fig-
ures 2B and 2C). This qualitative analysis suggested that the size
of the acetylproteome, defined by the number of acetylation sites
identified, more than doubled (222% increase) in response to
chronic HF feeding; whereas the identification of internal stan-
dard acetylated BSA peptides, spiked at 5 ppm into all samples,
was similar between diets (Figure 1B). Additionally, when repre-
sented by proteins containing at least one identified acetylation
site, the identified protein acetylome expanded by nearly this
same amount (172%) in the HF compared to LF diet condition
(Figure 2D). Thus, in addition to increasing the number of acety-
lation sites identified at a fixed FDR, the HF diet appeared to
augment the total number of proteins harboring at least one
Figure 1. Carnitine and CrAT Mitigate Acetyl-CoA-Induced Acetylation of Mitochondrial Proteins In Vitro
(A andB) Representative anti-acetyllysine western blots of permeabilizedmitochondria fromquadricepsmuscle from (A) C57BL6mice or (B) Control (CrATfl/fl) and
CrAT-deficient (CrATskm/) mice, incubated ± 2.5 mM acetyl-CoA and ± 5 mM L-carnitine (60 min, 32C, pH 8.0).
(C) Corresponding quantification of the band intensities (entire lane) for (B).
(D and E) Quadriceps muscles from CrATfl/fl and CrATskm/ mice fed a high fat diet for 12 weeks were used for (D) measurement of tissue acetyl-CoA levels
normalized to an internal standard (IS) (data are mean ± SEM; n = 5) and (E) western blot analysis of CrAT protein (upper panel) and lysine acetylation (lower panel)
in mitochondria isolated from CrATskm/ (KO) and CrATfl/fl mice (wild-type [WT]).
See also Figure S1.detectable acetyl-lysine modification. To begin assessing char-
acteristics shared among muscle proteins with diet-induced al-
terations in acetylation, we used the open source web tool
db2 db (Mudunuri et al., 2009) to quantify the percentage of pro-
teins that localize to the mitochondrial, cytosolic, and/or nuclear
compartments in both the LF and HF conditions. Interestingly,
63% of the acetylated proteins identified exclusively in the HF
diet group are resident mitochondrial proteins, whereas those
specific to the LF group were comprised of only 32% mitochon-
drial proteins (Figure 2D).
CrAT Deficiency Exacerbates Nutrient-Induced
Acetylation of Mitochondrial Proteins
To gain further insights into the role of CrAT in influencing mito-
chondrial protein acetylation, we next performed a label-free
quantitative protein acetylomic comparison of quadriceps mus-
cles from CrATfl/fl and CrATskm/ animals, fed either a LF or HF
diet for 12 weeks. This label-free quantitation strategy included
the CrATfl/fl animals used for the forgoing qualitative diet
comparison (Figures 2C and 2D), but nowwith the addition of ge-
notype comparisons (Figures 2A and 2B). Alignment of mass
spectral features between runs was performed informaticallyCfor quantitative assessment of the area under theMS1-extracted
ion chromatograms for each feature (i.e., acetylpeptide). Prelim-
inary analysis showed that the impact of CrAT deletion wasmuch
more pronounced in the context of diet-induced obesity; thus we
proceeded to analyze the dataset from mice consuming the HF
diet in greater detail (see Table S1 for in-depth analysis of the
HF diet acetylproteomic data).
In mice fed the HF diet, we identified 1,087 aligned peptide
features containing at least one acetylated lysine residue at a
1% FDR (Figures 2B and 2E; Table S1). These acetylpeptides
mapped to a total of 236 acetylated proteins. For quantitative
comparison between genotypes, acetylpeptides were selected
and robust mean normalization (top and bottom 10% signals
excluded) was performed to reduce quantitative bias. Whereas
116 proteins were assigned only one quantified acetylpeptide,
an additional 100 proteins had multiple acetylpeptides. A small
number (16 proteins) had more than ten sites quantified, while
138 quantified acetylpeptides were assigned to a single struc-
tural protein, myosin 4. Considering a predicted quantitative
FDR of <5% (p < 0.05, after adjusting for multiple hypotheses),
157 acetylpeptides increased with loss of CrAT (Figure 2E).
Of the 59 acetylpeptides that decreased with loss of CrATell Reports 14, 243–254, January 12, 2016 ª2016 The Authors 245
Figure 2. High Fat Feeding Expands the Detectable Acetyl-Proteome in Skeletal Muscle
(A) Schematic of the experimental workflow. After 12 weeks of feeding either a low fat (LF) or high fat (HF) diet, mouse quadriceps muscles were excised and
protein extracted. Acetylated BSA standard was added to each sample prior to protein digestion. Peptides were immunoprecipitated (IP) with anti-acetyl lysine
antibody and acetylpeptides were analyzed using high resolution LC-MS/MS to evaluate the acetylpeptide inventory and perform label-free quantitation.
(B) Qualitative summary and data metrics for acetylpeptides identified at 1% FDR in quadriceps muscles from CrATskm/ and CrATfl/fl mice.
(C) Venn diagram showing overlap between non-redundant sites of acetylation mapped by acetylpeptides identified at 1% FDR in quadriceps muscles from
CrATfl/fl mice fed a LF compared to HF diet.
(D) Corresponding bar graph indicating the number of skeletal muscle proteins from CrATfl/fl mice containing at least one acetylation site, with the dark-shaded
region indicating the fraction localizing to the mitochondrion.
(E) Volcano plot of the abundance of quantified acetylpeptides in muscles from mice fed a HF diet, expressed as the fold change detected in CrATskm/ as
compared to the CrATfl/f group, versus the statistical significance of those differences. The x axis indicates the magnitude of the fold changes in abundance
(legend continued on next page)
246 Cell Reports 14, 243–254, January 12, 2016 ª2016 The Authors
Figure 3. CrAT Deficiency Exacerbates Nutrient-Induced Acetylation of Mitochondrial Proteins
Acetylproteomic analyses were performed on quadriceps muscles from CrATskm/ and CrATfl/f mice fed a high fat diet for 12 weeks.
(A) Two-dimensional agglomerative cluster analysis using Z score transformed data showing 32 acetylpeptides that differed in abundance between genotypes by
at least 2.0-fold (adjusted p < 0.05). Yellow indicates acetylpeptides increasing up to 3-fold, and blue indicates acetylpeptides decreasing up to 3-fold in the
CrATskm/ mice relative controls. Pixels outlined in white indicate CrAT acetylpeptides.
(B) Localization annotation (gene ontology) was assessed for 154 acetylpeptides (mapping to 69 proteins) that were increased at least 1.5-fold (up) and 27
acetylpeptides (mapping to 18 proteins) that were decreased at least 1.5-fold (down) in CrATskm/mice relative to controls. For both pie charts, the yellow area
represents the percentage of peptides mapping to mitochondrial-localized proteins (96% of those increased), with blue indicating the percentage of peptides
mapping to non-mitochondrial proteins (97% of those decreased).
(C) Pathway assessment (Ingenuity algorithm) for acetylation events that increase in CrATskm/mice relative to controls. The bar graph indicates the significance
(–log p values) of each pathway as being enriched for changing acetylation.
(D) Pathway analysis (as in C) for acetylation events that decrease in CrATskm/ mice relative to controls.expression, twomapped to theCrAT enzyme itself (circled in Fig-
ure 2E). Only one internal standard acetylpeptide (mapping to the
yeast alcohol dehydrogenase internal control added post-immu-
noprecipitation [IP]) was among the 216 acetylpeptides passing
our significance threshold, whereas the other 35 internal stan-
dard acetylpeptides (all from acetylated BSA added prior to
digestion, see black dots in Figure 2E) were unchanged, yielding
a calculated quantitative FDR of <1% (1 out of 216), well below
our predicted quantitative FDR (5%).
Using Z score transformed data we performed a two-dimen-
sional agglomerative cluster analysis of 32 acetylpeptides that
differed in abundance between genotypes by at least 2.0-fold
(adjusted p < 0.05). This analysis revealed a robust and perfectly(arithmetic scale) as well as directionality (negative numbers indicate a decrease i
downregulated and upregulated peptides (adjusted p < 0.05, or –log10 adjusted p
and red, respectively.
See also Table S1.
Csorted genotype-specific acetylation pattern wherein acetylpep-
tides increased (yellow) in the CrATskm/ muscles belonged
exclusively to mitochondrial proteins (Figure 3A). Acetylpeptides
that decreased (blue) in response to CrAT deficiency belonged
exclusively to cytosolic proteins, with the single exception of
CrAT itself (highlighted by a white outline around the heat maps
pixels in Figure 3A), which was present only in the CrATfl/fl control
group and found to be acetylated on two lysine residues. To
investigate the possibility of coordinated changes within com-
mon cellular pathways, we lowered the differential abundance
threshold to 1.5-fold (adjusted p < 0.05), which revealed 91
acetylpeptides—belonging to 55 proteins—that were more
abundant in the CrATskm/ compared to CrATfl/fl muscles (seen KO), and the y axis shows the adjusted p values in –log10 space. Significantly
> 1.3) in CrATskm/ quadriceps are contained within the dotted boxes in blue
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Table S1). Of those 55 proteins, 96% were assigned to the mito-
chondrial compartment (Figure 3B) and encompassed a broad
range of bioenergetic processes as determined by Ingenuity
Pathway Analysis (http://www.Ingenuity.com) (Figure 3C).
A much a smaller subset of 37 acetylated peptides were less
abundant in the CrATskm/ muscles. Disregarding the geneti-
cally-engineered decrease in CrAT and the internal standard
that was added (both highlighted in Figure 2E), 97%of the acetyl-
peptides that decreased with CrAT deficiency belonged to
non-mitochondrial proteins (Figure 3B) involved in muscle
contraction, structural components, glucose metabolism, and
vesicle trafficking (Figure 3D).Western blot analysis of total abun-
dance of several mitochondrial proteins, including citrate syn-
thase and multiple oxidative phosphorylation complex subunits,
were unremarkable, suggesting that loss of CrAT did not alter
relativemitochondrialmass (Figures S1AandS1B). Protein levels
of SIRT3 were likewise unaffected by genotype (Figure S1C).
To evaluate sub-organelle localization of acetylated proteins,
we analyzed our list of acetylated peptides against the Broad
Institute’s MitoCarta compendium (Pagliarini et al., 2008)—an
expansive inventory of mitochondrial proteins and their sub-
compartment localization within the matrix and inner membrane
space (IMS) (Hung et al., 2014; Rhee et al., 2013) (Figure 4A; Ta-
ble S1). Interestingly, whereas only 42% of proteins inMitoCarta
map to the matrix (Figure S2A), 81% of the acetylpeptides iden-
tified in the present study were assigned to matrix proteins (Fig-
ure S2B), along with 88% of the mitochondrial acetylpeptides
(127/144) that increased significantly (adjusted p < 0.05) with
CrAT deficiency (Figure 4B). Only three matrix acetylpeptides
decreased in CrATskm/ mice (Figure 4A) (two belonging to
CrAT). Although 15% of mitochondrial-localized acetylpeptides
that increasedwith CrAT deletion were assigned to IMS proteins,
this subset was enriched for proteins that dually localize to the
matrix, presumably proteins that span the inner mitochondrial
membrane. Manual inspection of acetylpeptides increased
with CrAT deletion but currently lacking sub-mitochondrial clas-
sification revealed that these too are likely to reside in the matrix.
Figure 4C provides a map of mitochondrial acetylation sites in
pathways that were found to be enriched for hyperacetylation
in CrAT-deficient muscles, illustrating the broad range of meta-
bolic pathways affected. To determine whether a similar acetyl-
proteomic profile would emerge from humans, we analyzed
quadriceps biopsies from nine overweight subjects (assessed
in three pooled samples of three), all with BMIR 29. We identi-
fied a total of 515 acetylpeptides at a 1% FDR, 16 of which were
generated from our acetylated BSA internal standard (Table S2).
A subset of 198 acetylpeptides mapped to mitochondrial pro-
teins, of which 163 belong to proteins that localize to the mito-
chondrial matrix (Figure S2D), consistent with the animal models.
Moreover, analysis of both mouse (Figures S2A and S2B) and
human (Figures S2C and S2D) muscle tissues showed that the
relative number of acetylation events on matrix (compared to
non-matrix) targets exceeds the relative distribution of proteins
comprising these compartments by a factor of two (i.e., 81%–
82% of acetylated mitochondrial peptides map to matrix pro-
teins whereas the total mitochondrial proteome consists of
only 41%–42% matrix proteins). Taken together, these results
support the notion that mitochondrial matrix proteins are partic-248 Cell Reports 14, 243–254, January 12, 2016 ª2016 The Authorsularly susceptible to non-enzymatic lysine acetylation in
response to chronic caloric surplus (Ghanta et al., 2013; Wagner
and Payne, 2013).
In Silico Structural Analysis and Modeling of
Acetylpeptides and Proteins Increased by CrAT
Deficiency
We next sought to gain insight into the tertiary environments of
the acetylated mitochondrial residues affected by CrAT defi-
ciency, presuming that acetylation events driven by mass action
would tend to occur on exposed sites that are more likely to
encounter an acetyl donor. To this end, we performed in silico
homology-based three-dimensional structure modeling using
the open source SWISS-Model Repository (Kiefer et al., 2009),
which was applied to only those peptides (40 total) belonging
to mouse proteins (23 total) with a sequence identity of R90%
when compared to the protein used to generate the crystal struc-
ture. Interestingly, 100%of the 40 acetyl-lysine residuesmeeting
the above criteria were predicted as solvent exposed sites that
protrude away from the surface of the protein. For example, Fig-
ure 5A shows a PyMOL-generated image of the acetyl sites (in
red) identified on the 11-subunit crystal structure of dihydroli-
poamide dehydrogenase (Dld), which functions as the E3 sub-
unit of several dehydrogenase complexes, including PDH,
aKDH, and BCKD. Figure 5B provides a model of the secondary
structure locations of acetyl sites identified within the tetrameric
structure of Mdh2, the mitochondrial isoform of malate
dehydrogenase.
The open source Icelogo web application (Colaert et al., 2009)
was then used to visualize conserved sequence patterns in the
acetyl peptides identified in CrAT null muscles as compared to
those detected in the control group. First, the primary amino
acid sequence of the 14 residues flanking each mitochondrial
acetyl site was compared against all non-acetylated lysine
residues belonging to the same mitochondrial proteins (i.e.,
reference set) (Figure 5C). Frequencies of residues that
were significantly (adjusted p < 0.05) overrepresented (positive
y axis) or underrepresented (negative y axis) in each position
are represented in Figure 5D by the height of the single-letter
amino acid abbreviations. As compared to the reference set,
analysis of the set of acetyl peptides that were increased in
CrAT null muscles revealed a clear overrepresentation of acidic
residues (mainly glutamate and aspartate) in the immediate
neighborhood of the acetylated lysine, along with a duplex of
adjacent lysine residues at positions +6 and +7. A similar but
less pronounced pattern emerged when the analysis was per-
formed using mitochondrial acetyl sites that were unchanged
between genotypes (not shown). In sum, these observations
are consistent with the premise that some lysine residues are
more vulnerable to non-enzymatic acetylation than others due
to their primary, secondary, and tertiary protein structures
(Ghanta et al., 2013; Hebert et al., 2013).
HyperacetylationofMitochondrialProteins inCrATskm/
Mice Is Accompanied by Impaired Whole Body Glucose
Homeostasis
Because studies in Sirt3 knockout (KO) mice have linked hyper-
acetylation of mitochondrial proteins to increased susceptibility
Figure 4. Mitochondrial Matrix Proteins Are Highly Susceptible to Lysine Acetylation Induced by Diet and CrAT Deficiency
(A) Table showing number of acetylated peptides significantly changing in CrATskm/ mice relative to CrATfl/f controls in the context of the HF diet, binned by
mitochondrial localization. Analysis was performed by mapping the current dataset to the Broad Institute’s MitoCarta proteome inventories of the mammalian
mitochondrion, the mitochondrial matrix (Matrix) and the mitochondrial inner membrane space (IMS). Acetylpeptides mapping to proteins with overlapping
localization to both the Matrix and IMS were considered for both categories. MitoCarta proteins that were not found to be Matrix or IMS were considered
‘‘Unclassified’’ and proteins not contained in the MitoCarta were considered non-mitochondrial (non-Mito).
(B) Venn Diagram showing the submitochondrial localization of acetylation events increasing in CrATskm/ relative to CrATfl/f controls. Thewhite circle represents
the relative number of acetylpeptides across the entire mitochondrion, black represents the matrix, and gray represents the IMS, with compartmental overlap
depicted.
(C) Map of mitochondrial metabolic pathways with increased abundance of acetylated proteins in muscle from CrATskm/ mice. Black ‘‘lollypops’’ depict
acetylpeptides within pathways detected by the Ingenuity algorithm as having increased acetylation in CrATskm/ mice (Figure 3C), with each symbol repre-
senting an individual acetylated lysine.
See also Figure S2 and Table S2.
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Figure 5. In Silico Structural Analysis and
Modeling of Acetylpeptides and Proteins
Increased by CrAT Deficiency
(A) Structure (PDB: 2f5z) of the E3 complex of
pyruvate dehydrogenase (Dld) showing acetylated
lysine residues (AcK) that increased in the
CrATskm/ (highlighted in red). Residues in or-
ange represent the FAD-linked lipoamide arm of
the enzyme. Modeling was performed using
PyMOL.
(B) Structure (PDB: 2dfd) of mitochondrial malate
dehydrogenase 2 (Mdh2) showing localization of
acetylated residues. AcK highlighted in red
represent differentially abundant PTMs identified
from CrATskm/ mice, whereas those in yellow
were unchanged between genotypes.
(C) Icelogo analysis was performed by comparing
the amino acid landscape surrounding AcKs
identified in CrATskm/ muscle to a mouse refer-
ence set containing information about the identity
of the amino acids in the same 28 positions
neighboring lysine residues in all mouse proteins.
(D) The top results show the enrichment of amino
acids seven residues N (negative)- or C (positive)-
terminal to acetylated lysines (centered at posi-
tion ‘‘0’’) identified to be increased in CrATskm/
muscle compared to controls after 12 weeks of
high fat diet feeding. The bottom results show the
enrichment of amino acids surrounding the
average lysine present in mouse proteins. Letters
are color coded according to amino acid type
using the scheme shown in (C).to diet-induced glucose intolerance and muscle insulin resis-
tance (Lantier et al., 2015), we sought to determine whether a
similar phenotype would manifest in the CrATskm/ mice.
Indeed, following 12 weeks of HF feeding, the diet-induced
decline in whole body glucose homeostasis was more severe
in CrATskm/ as compared to their CrATfl/fl littermates (Figures
6A–6D). Both the HOMA index of insulin resistance (Figure 6A)
and blood glucose excursions during an intraperitoneal (i.p.)
glucose tolerance test (Figures 6B and 6C) were elevated in
CrAT-deficient mice, whereas lowering of blood glucose in
response to an insulin tolerance test was blunted (Figure 6D).
Although these observations do not prove causation, they are
consistent with mounting evidence that an upward shift in the
acetylation state of mitochondrial proteins is often accompa-
nied by perturbations in insulin action and whole body meta-
bolic control (Hirschey et al., 2011; Jing et al., 2011; Lantier
et al., 2015).
DISCUSSION
The current study deployed mass spectrometry-based acetyl-
proteomics to examine the interplay between nutrient load250 Cell Reports 14, 243–254, January 12, 2016 ª2016 The Authorsand protein acetylation in skeletal mus-
cle, and to test the hypothesis that lysine
acetylation of mitochondrial proteins
fluctuates in response to local concen-
trations of acetyl-CoA. This carbon loadconcept of mitochondrial protein acetylation is gaining
increasing support, but has thus far relied on circumstantial
evidence. Here, we used CrAT ablation in skeletal muscle as
a targeted genetic maneuver to induce a compartment-specific
rise in tissue acetyl-CoA levels in the context of contrasting
nutrient conditions. We report two major findings. First, HF
feeding resulted in an approximate doubling of the number of
unique acetylation sites and acetylated proteins identified in
whole muscle tissue, and the subset of acetylpeptides de-
tected only in the context of HF feeding belong to proteins
that reside predominately in the mitochondrion. Second,
genetic disruption of mitochondrial acetyl group buffering
capacity due to deletion of the CrAT enzyme increased muscle
abundance of a large number of lysine acetylpeptides
belonging to mitochondrial proteins. Further, while our acetyl
proteomic analysis was conducted with whole-tissue lysates,
the effect of CrAT deficiency was largely specific to the mito-
chondrial matrix compartment and detected principally under
conditions of chronic overfeeding. These results provide strong
in vivo experimental evidence directly linking perturbations in
mitochondrial acetyl group balance to broad-scale changes in
the mitochondrial matrix acetylproteome. The findings also
Figure 6. Hyper-Acetylation of Mitochon-
drial Proteins in CrATskm/Mice Is Accom-
panied by Glucose Intolerance
CrATfl/fl and CrATskm/ mice were fed a high fat
diet for 8 weeks prior to assessment of glucose
control obtain in the morning after a 2 hr fast.
(A) HOMA insulin resistance (IR) index (n = 5–8 per
group, *p < 0.05 versus CrAT fl/fl by Student’s
t test).
(B) Glucose tolerance test performed using i.p.
injection of 2 g glucose per kg bodyweight (n = 5–8
per group, *p < 0.001 by Student’s t test).
(C) Area under the curve from the tests shown in
(B) (*p < 0.005 by Student’s t test).
(D) Insulin tolerance test performed using i.p. in-
jection of 0.75 U Humulin per kg bodyweight (n =
5–8 per group, *p < 0.001 by Student’s t test).establish a role for the L-carnitine/CrAT buffering system in
regulating protein acetylation within the mitochondrial matrix,
which may help to explain why total acetylation of mitochon-
drial proteins trends lower in skeletal muscle as compared to
other metabolic tissues (e.g., liver) when measured in the
context of a standard chow diet (Dittenhafer-Reed et al.,
2015; Overmyer et al., 2015).
The importance of acetyl modifications in regulating subcel-
lular localization, stability, and activity of cytoplasmic and nu-
clear proteins is well established (Glozak et al., 2005; Ozden
et al., 2011). Acetylation events occurring in these compart-
ments are catalyzed by several known protein acetyltransferase
(KATs) that are counteracted by proteins belonging to the his-
tone deacetylase and sirtuin deacetylase families. Interest in
mitochondrial protein acetylation has escalated with the dis-
covery that a subset of the sirtuin deacylases resides in the
mitochondrial matrix (SIRT3-5), implying important regulatory
roles for these PTMs in oxidative metabolism. Studies of mito-
chondrial protein acetylation have centered on characterizing
overall coverage of acetyl-occupied lysine residues and their
potential regulation by SIRT3. Notably however, SIRT3 acts
only to counterbalance the acetylation side of the equation.
Delineating the factors that influence the on-rate of these reac-
tions could be equally important. Because compelling evidence
of a bona fide mitochondrial-localized KAT has yet to emerge,
mounting speculation posits that mitochondrial lysine acetyla-
tion occurs non-enzymatically via mass action when a deproto-
nated lysine side-chain reacts with the thioester of acetyl-CoA.
Fitting with this prediction, the present study showed that CrAT
loss-of-function increased tissue levels of acetyl-CoA and
exacerbated the impact of HF feeding on the mitochondrial
protein acetylome.
Interestingly, genotype-dependent differences in muscle
acetyl-CoA content were statistically significant, but relativelyCell Reports 14, 243–254modest. However, it is important to
consider that measurements made in
whole tissue at a single time point prob-
ably underestimate dynamic physiolog-
ical fluctuations occurring specificallywithin the mitochondrial matrix, and/or the microenvironments
surrounding the affected metabolic enzymes. Additionally, tran-
sient spikes in the availability of acetyl donors might be quickly
buffered by the mitochondrial proteome. For example, a recent
study that quantified site-specific stoichiometry of the entire
Escherichia coli proteome estimated that the amount of acetate
on proteins is 2 mM (Baeza et al., 2014). We therefore suspect
that much of the acetyl-CoA surplus in CrATskm/ mice is
sequestered by mitochondrial proteins, in essence trapping car-
bons within this compartment. This explanation could account
for the finding that CrAT deficiency resulted in reduced acetyla-
tion of proteins residing outside the mitochondria.
Acetyl-CoA holds a prominent position in mitochondrial meta-
bolism as the universal oxidative end product of glucose, fatty
acid, and amino acid catabolism. Additionally, pumping of pro-
tons from themitochondrial lumen to the inner membrane space,
which is mediated by the electron transport chain, maintains the
matrix pH within an alkaline range closer to the pKa of lysine res-
idues (Ghanta et al., 2013; Wagner and Payne, 2013). Thus, in
theory, the chemical conditions of the mitochondrial matrix are
conducive to non-enzymatic lysine acetylation, which requires
a deprotonated lysine primary amine. A recent in vitro study
found that lysine reactivity for non-enzymatic acetylation is
site-specific, depending on the primary, secondary, and tertiary
structure of the protein (Baeza et al., 2015). In the current inves-
tigation, analysis of structural and chemical features of the acet-
ylation sites found to be more abundant in CrAT-deficient
muscles revealed some interesting trends. First, structural pre-
dictions based on in silico modeling of mitochondrial protein
acetylation sites found to be more abundant in CrAT-deficient
muscles universally positioned these events on solvent exposed
lysine residues that protrude away from the surface of the pro-
tein. We interpret this finding to suggest that this subset of acetyl
modifications occurred after proper protein folding and complex, January 12, 2016 ª2016 The Authors 251
assembly, which could have implications for understanding the
stoichiometry and functional relevance of these events. Second,
Icelogo analysis of primary sequence motifs revealed an over-
representation of negatively charged residues, mainly glutamate
and aspartate, in the immediate neighborhood of the mitochon-
drial protein acetylation sites responsive to CrAT inactivation, as
well as a slightly more distant cluster of positively charged lysine
residues. As recently suggested (Ghanta et al., 2013), this motif
could reflect a local environment that effectively lowers the pKa
of the targeted lysine, increasing the likelihood of deprotonation
and thereby rendering the site susceptible to nucleophilic attack
and acyl modification.
An important and yet unanswered question in this field is
whether widespread acetylation of mitochondrial proteins repre-
sents a bona fide regulatory mechanism, and/or a form of protein
damage that comes as a cost of the permissive metabolic envi-
ronment. As discussed previously, these two possibilities are not
mutually exclusive (Ghanta et al., 2013). Thus, high occupancy
acetylation sites with perturbed pKa values might have evolved
to permit macronutrient-induced modification and regulation of
proteins in a manner that optimizes energy partitioning and stor-
age during periods of carbon surplus (Ghanta et al., 2013). Also
uncertain is whether global shifts in lysine acetylation have a
physiologically relevant impact on cellular function, especially
considering that many of these events appear to occur at low
stoichiometry (Baeza et al., 2014; Weinert et al., 2015). Nonethe-
less, a growing number of studies using site-directed mutagen-
esis strategies show that at least some of these modifications
alter activity of mitochondrial proteins, mostly in a negative di-
rection (Hallows et al., 2006, 2011; Hirschey et al., 2010; Still
et al., 2013), although gain-of-function acetylation events have
been reported (Fernandes et al., 2015; Lu et al., 2015). Lysine
acetylation has also been linked to nutrient control of autophagy
and mitophagy (Webster et al., 2014). Although these processes
appear to be regulated by acetylation of specific proteins that
reside outside the mitochondrial matrix, including some that
localize to the outer mitochondrial membrane, the current find-
ings suggest hyperacetylation of the matrix proteome might
have a reciprocal effect on AcK events in other compartments.
Still, the list of functionally relevant AcK targets is small in com-
parison to the breadth of sites that have been identified (Choudh-
ary et al., 2009; Dittenhafer-Reed et al., 2015; Hebert et al., 2013;
Kim et al., 2006; Rardin et al., 2013). Herein, perturbations in the
acetylproteome of the CrATskm/mice coincided with impaired
glucose tolerance, which aligns with a number of observational
studies linking heightened mitochondrial acetylation and/or
SIRT3 insufficiency to metabolic dysregulation. Also noteworthy
is that obesity andHF feeding have been shown to diminish CrAT
activity in skeletal muscle (Lindeboom et al., 2014; Seiler et al.,
2014) and L-carnitine supplementation increases tissue acetyl-
carnitine production and efflux while also improving metabolic
control when administered to obese rodents and humans (No-
land et al., 2009; Ringseis et al., 2012). Taken together with the
current findings, these results prompt speculation that the ther-
apeutic benefits of L-carnitine supplementation might stem from
its actions to combat stress-induced acetylation of mitochon-
drial proteins, including CrAT itself. This is an intriguing possibil-
ity now deserving of further investigation.252 Cell Reports 14, 243–254, January 12, 2016 ª2016 The AuthorsEXPERIMENTAL PROCEDURES
Animal Studies
All procedures were approved by the Duke University Institutional Animal Care
and Use Committee. Mice had free access to food and water and were fed a
standard chow (Purina Rodent Chow no. 5001, PurinaMills) prior to being fed a
semi-purified 10% fat diet (Research Diets, D12450B) or a 45% fat diet
(Research Diets, D03021303) for 12 weeks. The genetic strategy used for
generating CrATfl/fl and CrATskm/ mice was described previously (Seiler
et al., 2015). Glucose tolerance and insulin tolerance tests were performed
in themorning 1 hr after food withdrawal. Mice were singly housed with access
to water (gel pack). After taking glucose reading using a glucometer at the
0 min time point, mice were given an intraperitoneal injection of 2.0 g glucose
per l g body or 0.08 U/mouse Humulin, both dissolved in saline. Blood for
ELISA insulin measurements was collected at 0, 15, and 60 min. At the time
of harvest for proteomics analysis, weights of mice fed the high fat diet aver-
aged 38.6 g (1.1 STE, n = 5) for CrATfl/fl and 41.1g (1.8 STE, n = 8) for
CrATskm/. At time of the glucose tolerance test, animals weighed 27.5 g
(STE 0.8, n = 5) for CrATfl/fl, and 37.5g (1.6 STE, n = 8) for CrATskm/.
In Vitro Mitochondrial Incubations
Mitochondria were enriched from CrATfl/fl and CrATskm/ quadriceps and
gastrocnemius as described in the Supplemental Experimental Procedures.
Mitochondrial lysates (100 mg protein) were incubated in CrAT activity buffer
(50 mM Tris-HCl, 1 M EDTA, 1 mM nicotinamide (NAM), 1 mM trichstatin A
(TSA), protease inhibitor cocktail (Sigma P8340); pH 8.0) at 1 mg/ml. Treatments
included 2.5mMAcetyl-CoA and 5mML-carnitine. Mitochondrial lysates were
incubated at 32C for 1 hr. Reactions were stopped by placing lysates on ice
and transferred to the 80C.
Metabolic Profiling
Acyl-CoAs were extracted from quadriceps tissue and analyzed by flow injec-
tion tandemmass spectrometry as described previously (An et al., 2004; Seiler
et al., 2015).
Quantitative Proteomics
Pulverized quadriceps tissue samples were solubilized in 8 M urea-containing
buffer as described in the Supplemental Experimental Procedures. After 30 ng
acetylated-BSA serum albumin (Ac-BSA) was added as an internal standard to
each protein sample (5mg), cysteine residues were reducedwith dithiothreitol,
alkylated with iodoacetamide, and digested with trypsin overnight. Peptide
samples were desalted, lyophilized, and subjected to immunoprecipitation
with Acetyl-K PTMScan enrichment beads (Cell Signaling Technology).
Peptides were eluted, desalted, lyophilized, and re-suspended along with
10 fmol/ml of yeast aldehyde dehydrogenase (ADH1_YEAST) MassPrep Stan-
dard (Waters). Samples were subjected to label-free quantitative LC/MS/MS
using a nanoAcquity UPLC system (Waters) coupled to a LTQ-Orbitrap XL
high resolution accuratemass tandemmass spectrometer (Thermo Fisher Sci-
entific) via a nanoelectrospray ionization source. The raw data were analyzed
using Rosetta Elucidator v3.3 (Rosetta Biosoftware). All LC-MS/MS runs were
aligned using the PeakTeller algorithm (Elucidator) and relative peptide abun-
dances were calculated based on area-under-the-curve (AUC) of aligned
features across all runs. The MS/MS data were searched against a custom
database of ‘‘target’’ sequences consisting of NCBI RefSeq Mus musculus
proteins along with internal standards and ‘‘decoy’’ reversed-sequences for
false positive rate determination (Elias and Gygi, 2007). Database searching
was performed with the Elucidator software package using Mascot search
engine (v2.2), assigning precursor ion tolerance of 5 ppmand product ion toler-
ance of 0.8 Da. Searching allowed variable modification of N and Q (dea-
midation, +1 Da), M (oxidation, +16 Da), and K (acetylation, +42 Da). After
aggregating all search results, annotation (assignment of peptide sequence
to the quantitative MS signal) was performed for peptides whose ion score
was >30. For the high fat diet cohorts, this resulted in a total of 4,204 peptides
mapping to 932 proteins, including 1,111 peptides containing at least one
acetylated K residue, at 1% peptide FDR. For quantitative processing, the
data were first curated to contain only high quality peptides with appropriate
chromatographic peak shape (1,087 acetylpeptide features in the high fat
fed mice). See the Supplemental Experimental Procedures for more details.
Analyzed data for the high fat diet cohorts are included in Table S1. Analyzed
data for the human pilot study are provided as Table S2. All raw mass
spectrometry files for the acetylproteomics work described herein are avail-
able online through Chorus (https://chorusproject.org, Public Project ID989)
via the following links: LF and HF diet mouse acetylproteomics (Public Exper-
iment ID2047), https://chorusproject.org/anonymous/download/experiment/
22e926ba037a45d79abb3dd51e24d3df; and human pilot study acetylproteo-
mics (Public Experiment ID2048), https://chorusproject.org/anonymous/
download/experiment/50216a62d2284df1a991eb2cc96fa1c3.
In Silico Analysis
The three-dimensional structure analysis was performed using the SWISS-
MODEL repository program (Kiefer et al., 2009). The SWISS-MODEL Re-
pository is a database of annotated three-dimensional comparative protein
structure models generated by the fully automated homology-modelling pipe-
line. The sequence identity threshold was set at 90% sequence homology.
The crystal structure imaging incorporating the acetyl sites was performed
using PyMOL. Assigned PDB names included PDB: 2f5z (Dld) and PDB:
2dfd (MDH).
The amino acid sequence motif analysis was performed using the Icelogo
web analysis tool (Colaert et al., 2009) as described in the figure legends. Fre-
quency analysis was plotted as percent difference with an adjusted p < 0.05.
For pathway analysis, a list of increased acetylpeptides (1.5-fold increase,
adjusted p < 0.05) was analyzed through the use of QIAGEN’s Ingenuity
Pathway Analysis (IPA) (QIAGEN Redwood City, http://www.Ingenuity.com).
Analyses of Human Muscle
Acetylproteomic analysis of human muscle was conducted on biopsy speci-
mens obtained from nine individuals, eight female and one male with a mean
age of 57, ranging from 55–67 years, and a mean body mass index of 32.8,
ranging from 29–35, with fasting blood glucose levels ranging from 82–
105 mg/dl. Human studies were performed at Duke University Medical Center
and were approved by the Duke University Health System Institutional Review
Board. Written informed consent was obtained from all subjects prior to inclu-
sion in the study.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
two figures, and two tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2015.12.030.
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